Home News & Events Events Workshops Workshops Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 19 May 2026 - 20 May 2026 Time 08:00 - 18:00 Location Online/Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 21 May 2026 Time 09:00 - 17:00 Location Online/Webex Timezone America/New York Workshop New and Advanced Features of NONMEM 7.6 Workshop Date 1 June 2026 Time 09:00 - 17:00 Location Dubrovnik, Croatia Timezone Europe/Bratislava In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Event Webinars Event Industry Events What’s happening in ICON ICON Plc Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our ... 6 Apr 1 View post View webpage ICON Plc ICON’s Patient Centred Outcomes team advanced key research in 2025, with over 45 highly experienced specialists supporting programmes across major therapy areas. With twelve peer‑reviewed papers, two educational events... 6 Apr View post View webpage ICON Plc During World Parkinson’s Awareness Month, we recognise the urgency of advancing research that can improve outcomes for people living with Parkinson’s disease. ICON has supported numerous neurodegeneration programmes, he... 6 Apr View post View webpage ICON Plc ICON is pleased to participate in the upcoming PharmaSUG India Single Day Event, taking place on 11 April at the Eli Lilly office in Bangalore. Madhan Kumar, Statistical Programmer II, will deliver a presentation titled... 6 Apr View post View webpage ICON Plc Robust NMA depends on systematic feasibility assessment, careful network construction and rigorous model evaluation. The paper details the workflow from literature review to treatment ranking, highlighting the importan... 2 Apr View post View webpage ICON Plc Attending World Vaccine Congress? Stop by booth \#222 to meet the ICON team to learn how our experience across 180+ vaccine studies, end‑to‑end product development expertise, and fully integrated vaccine‑development solu... 1 Apr View post ICON Plc ICON will be attending the 20th #WRIB from 13–17 April at the Hyatt Regency Dallas. Meet ICON’s experts at booth \#31 to discuss how our PK, immunogenicity, biomarker, qPCR and flow cytometry expertise across small mole... 1 Apr View post View webpage ICON Plc 2026 marks the first real entry of high risk medical devices into EU JCAs. From implantable prosthetics to active implantable devices, 15 categories have been identified as early candidates. This shift represents a maj... 1 Apr View post View webpage ICON Plc At the PharmaSUG India Single Day Event on 11 April, hosted at the Eli Lilly office in Bangalore, ICON will be represented by Gomathi S, Statistical Programmer I. Gomathi will present the poster titled “Evolving submiss... 1 Apr View post View webpage ICON Plc Today \@WVCUS, join ICON plc experts for a working group discussion on ‘Vaccine trials: How AI shifts execution from static plans to living systems’. Learn more at 11:40 am: https://ow.ly/9Uk050Yr8VL 31 Mar View post View webpage ICON Plc Patient safety and data integrity are the primary concerns in early phase clinical trials. In the US sponsors generally follow one of two standards sets when conducting early phase trials: Good Manufacturing Practice (GM... 31 Mar View post View webpage ICON Plc Scientific rigor continues to shape payer expectations, and #AMCP2026 offers an important forum for advancing those standards. ICON will be at booth \#1412 to discuss approaches to robust evidence generation, real world ... 30 Mar View post View webpage
